Disc Medicine Statistics

Total Valuation

Disc Medicine has a market cap or net worth of $740.92 million. The enterprise value is $382.64 million.

Market Cap	740.92M
Enterprise Value	382.64M

Important Dates

The next estimated earnings date is Monday, May 13, 2024, before market open.

Earnings Date	May 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Disc Medicine has 24.68 million shares outstanding. The number of shares has increased by 2,046.81% in one year.

Shares Outstanding	24.68M
Shares Change (YoY)	+2,046.81%
Shares Change (QoQ)	+0.54%
Owned by Insiders (%)	13.38%
Owned by Institutions (%)	85.02%
Float	13.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.15
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.06, with a Debt / Equity ratio of 0.01.

Current Ratio	17.06
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -23.40% and return on invested capital (ROIC) is -26.24%.

Return on Equity (ROE)	-23.40%
Return on Assets (ROA)	-22.30%
Return on Capital (ROIC)	-26.24%
Revenue Per Employee	n/a
Profits Per Employee	-$1.03M
Employee Count	74
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Disc Medicine has paid $99,000 in taxes.

Income Tax	99,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.19% in the last 52 weeks.

Beta (1Y)	n/a
52-Week Price Change	+18.19%
50-Day Moving Average	55.86
200-Day Moving Average	53.62
Relative Strength Index (RSI)	24.06
Average Volume (30 Days)	450,162

Short Selling Information

The latest short interest is 1.86 million, so 7.53% of the outstanding shares have been sold short.

Short Interest	1.86M
Short Previous Month	1.26M
Short % of Shares Out	7.53%
Short % of Float	13.78%
Short Ratio (days to cover)	4.88

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-91.13M
Pretax Income	-76.33M
Net Income	-76.43M
EBITDA	-75.94M
EBIT	-76.33M
Earnings Per Share (EPS)	-$3.42

Full Income Statement

Balance Sheet

The company has $360.38 million in cash and $2.10 million in debt, giving a net cash position of $358.28 million or $14.52 per share.

Cash & Cash Equivalents	360.38M
Total Debt	2.10M
Net Cash	358.28M
Net Cash Per Share	$14.52
Equity / Book Value	345.12M
Book Value Per Share	13.98
Working Capital	344.22M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$73.46 million and capital expenditures -$89,000, giving a free cash flow of -$73.55 million.

Operating Cash Flow	-73.46M
Capital Expenditures	-89,000
Free Cash Flow	-73.55M
FCF Per Share	-$3.30

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Disc Medicine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2,046.81%
Shareholder Yield	-2,046.81%
Earnings Yield	-10.32%
FCF Yield	-9.93%

Dividend Details

Analyst Forecast

The average price target for Disc Medicine is $57.33, which is 90.97% higher than the current price. The consensus rating is "Buy".

Price Target	$57.33
Price Target Difference	90.97%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	0.15%

Stock Forecasts

Stock Splits

The last stock split was on December 30, 2022. It was a reverse split with a ratio of 1:30.

Last Split Date	Dec 30, 2022
Split Type	Reverse
Split Ratio	1:30

Scores

Altman Z-Score	n/a
Piotroski F-Score	2